Hospital Variation in Premature Clopidogrel Discontinuation After Drug-Eluting Stent Placement in the Veterans Affairs (VA) Healthcare System

被引:4
|
作者
Vigen, Rebecca [1 ]
Maddox, Thomas M. [2 ,3 ,4 ]
O'Donnell, Colin I. [2 ]
Grunwald, Gary K. [2 ,3 ]
Bhatt, Deepak L. [5 ,6 ]
Tsai, Thomas T. [2 ,3 ,4 ]
Rumsfeld, John S. [2 ,3 ,4 ]
Ho, P. Michael [2 ,3 ,4 ]
机构
[1] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
[2] VA Eastern Colorado Hlth Care Syst, 1055 Clermont St,Res A151, Denver, CO 80220 USA
[3] Univ Colorado Denver, Aurora, CO USA
[4] CCOR Consortium, Denver, CO USA
[5] Brigham & Womens Hosp, VA Boston Healthcare Syst, 75 Francis St, Boston, MA 02115 USA
[6] Harvard Med Sch, Boston, MA USA
来源
关键词
adherence; clopidogrel; drug-eluting stents; CARDIOVASCULAR-DATA-REGISTRY; ANTIPLATELET THERAPY; PREDICTORS; IMPLANTATION; PREVALENCE;
D O I
10.1161/JAHA.114.001376
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Premature clopidogrel discontinuation after drug-eluting stent placement is associated with adverse outcomes. Little is known about patient and hospital factors associated with premature discontinuation or whether less variation in premature discontinuation exists in integrated health care systems such as the Veterans Affairs (VA). Methods and Results-We evaluated the frequency of premature clopidogrel discontinuation, defined as a gap between clopidogrel refills of >= 90 days during the first 6 months of treatment, among 12 707 patients who received drug-eluting stents in VA hospitals between 2008 and 2010. We evaluated the association between premature discontinuation and all-cause mortality and/or acute myocardial infarction, variation in the proportion of premature discontinuation among hospitals, the patient and hospital characteristics associated with premature discontinuation, and the extent to which unexplained hospital characteristics contribute to premature discontinuation. Of the patients, 963 (7.6%) discontinued clopidogrel prematurely. Premature discontinuation was associated with acute myocardial infarction and all-cause mortality (hazard ratio 1.65, 95% CI 1.37-1.99, P<0.001). The proportion of patients with premature discontinuation varied across hospitals from 0% to 16.5% (P<0.001). We found a median of 24% greater odds of patients with identical covariates with premature discontinuation at one randomly selected hospital compared with another (median odds ratio 1.24, 95% CI 1.17-1.44). Patient factors associated with premature discontinuation included lack of cardiology follow-up within 30 days of discharge and smaller initial clopidogrel fill. Conclusion-One in 13 patients prematurely discontinued clopidogrel, and variation in discontinuation across hospitals was observed. Patient factors were associated with premature discontinuation that may represent targets for quality improvement.
引用
收藏
页数:7
相关论文
共 50 条
  • [11] Long-term clopidogrel therapy improves outcomes after drug-eluting stent placement
    Nature Clinical Practice Cardiovascular Medicine, 2007, 4 (4): : 176 - 177
  • [12] Successful Clopidogrel Desensitization after Drug-Eluting Stent Implantation
    Kammer, Ryan T.
    JOURNAL OF INVASIVE CARDIOLOGY, 2009, 21 (03): : 134 - 135
  • [13] Clopidogrel discontinuation within the first year after coronary drug-eluting stent implantation: an observational study
    Thim, Troels
    Johansen, Martin Berg
    Chisholm, Gro Egholm
    Schmidt, Morten
    Kaltoft, Anne
    Sorensen, Henrik Toft
    Thuesen, Leif
    Kristensen, Steen Dalby
    Botker, Hans Erik
    Krusell, Lars Romer
    Lassen, Jens Flensted
    Thayssen, Per
    Jensen, Lisette Okkels
    Tilsted, Hans-Henrik
    Maeng, Michael
    BMC CARDIOVASCULAR DISORDERS, 2014, 14
  • [14] Systemic inflammation after drug-eluting stent placement
    Gogo, PB
    Schneider, DJ
    Watkins, MW
    Terrien, EF
    Sobel, BE
    Dauerman, HL
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2005, 19 (02) : 87 - 92
  • [15] Clopidogrel discontinuation within the first year after coronary drug-eluting stent implantation: an observational study
    Troels Thim
    Martin Berg Johansen
    Gro Egholm Chisholm
    Morten Schmidt
    Anne Kaltoft
    Henrik Toft Sørensen
    Leif Thuesen
    Steen Dalby Kristensen
    Hans Erik Bøtker
    Lars Romer Krusell
    Jens Flensted Lassen
    Per Thayssen
    Lisette Okkels Jensen
    Hans-Henrik Tilsted
    Michael Maeng
    BMC Cardiovascular Disorders, 14
  • [16] Systemic Inflammation After Drug-Eluting Stent Placement
    Prospero B. Gogo
    David J. Schneider
    Matthew W. Watkins
    Edward F. Terrien
    Burton E. Sobel
    Harold L. Dauerman
    Journal of Thrombosis and Thrombolysis, 2005, 19 : 87 - 92
  • [17] Stopping or continuing clopidogrel 12 months after drug-eluting stent placement: the OPTIDUAL randomized trial
    Helft, Gerard
    Steg, Philippe Gabriel
    Le Feuvre, Claude
    Georges, Jean-Louis
    Carrie, Didier
    Dreyfus, Xavier
    Furber, Alain
    Leclercq, Florence
    Eltchaninoff, Helene
    Falquier, Jean-Francois
    Henry, Patrick
    Cattan, Simon
    Sebagh, Laurent
    Michel, Pierre-Louis
    Tuambilangana, Albert
    Hammoudi, Nadjib
    Boccara, Franck
    Cayla, Guillaume
    Douard, Herve
    Diallo, Abdourahmane
    Berman, Emmanuel
    Komajda, Michel
    Metzger, Jean-Philippe
    Vicaut, Eric
    EUROPEAN HEART JOURNAL, 2016, 37 (04) : 365 - 374
  • [18] Clopidogrel and long-term outcomes after drug-eluting stent implantation
    Matteau, Alexis
    LeLorier, Jacques
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (16): : 1770 - 1770
  • [19] Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis
    Buonamici, Piergiovanni
    Marcucci, Rossella
    Migliorini, Angela
    Gensini, Gian Franco
    Santini, Alberto
    Paruccia, Rita
    Moschi, Guia
    Gori, Anna Maria
    Abbate, Rosanna
    Antoniucci, David
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (24) : 2312 - 2317
  • [20] Prognostic Significance Of Clopidogrel Resistance After Coronary Drug-eluting Stent Implantation
    Wang, Zhi Jian
    Zhou, Yn Jie
    Liu, Yu Yang
    Yu, Miao
    Shi, Dong Mei
    Zhao, Ying Xin
    Guo, Yong He
    Cheng, Wan Jun
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (8A): : 76I - 76I